We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

59 hedge funds and large institutions have $15.9M invested in Q32 Bio in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,000% more call options, than puts

Call options by funds: $41K | Put options by funds: $1K

0.15% less ownership

Funds ownership: 1.87% → 1.72% (-0.15%)

5% less funds holding

Funds holding: 62 → 59 (-3)

21% less capital invested

Capital invested by funds: $20M → $15.9M (-$4.13M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

68% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 19

Holders
59
Holders Change
-3
Holders Change %
-4.84%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
19
Closed
10
Calls
$41K
Puts
$1K
Net Calls
+$40K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$31.7K
2
TSS
Two Sigma Securities
New York
+$10.8K
3
Squarepoint
Squarepoint
New York
+$10.2K
4
Bank of America
Bank of America
North Carolina
+$9.68K
5
UBS Group
UBS Group
Switzerland
+$5.12K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$411K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$204K
3
Citadel Advisors
Citadel Advisors
Florida
-$183K
4
Morgan Stanley
Morgan Stanley
New York
-$145K
5
BlackRock
BlackRock
New York
-$96.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CIC
26
Cornercap Investment Counsel
Georgia
$33.5K -$43.1K -2,403 -53%
AIS
27
American Investment Services
Massachusetts
$32.7K – – –
SIA
28
Schechter Investment Advisors
Michigan
$26.4K – – –
Goldman Sachs
29
Goldman Sachs
New York
$23.4K +$574 +32 +2%
Charles Schwab
30
Charles Schwab
California
$19.4K – – –
Mariner
31
Mariner
Kansas
$17.6K -$72 -4 -0.4%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$17.2K – – –
UBS Group
33
UBS Group
Switzerland
$14.5K +$5.12K +285 +46%
RJA
34
Raymond James & Associates
Florida
$14.1K – – –
HSBC Holdings
35
HSBC Holdings
United Kingdom
$14K – – –
Morgan Stanley
36
Morgan Stanley
New York
$11.5K -$145K -8,088 -92%
DCM
37
Dimension Capital Management
Florida
$9.69K -$5.04K -281 -32%
TSS
38
Two Sigma Securities
New York
$9.58K +$10.8K +601 New
Squarepoint
39
Squarepoint
New York
$9.03K +$10.2K +567 New
TYCC
40
Texas Yale Capital Corp
Florida
$8.85K – – –
Russell Investments Group
41
Russell Investments Group
United Kingdom
$3.85K -$30K -1,672 -87%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$3K +$1.83K +102 +123%
Wells Fargo
43
Wells Fargo
California
$1.91K – – –
US Bancorp
44
US Bancorp
Minnesota
$1.59K – – –
AWM
45
Ameliora Wealth Management
Switzerland
$1.33K – – –
NA
46
NewEdge Advisors
Louisiana
$1.29K +$987 +55 +212%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$1.04K +$1.17K +65 New
EWM
48
Endurance Wealth Management
Rhode Island
$1K – – –
JP Morgan Chase
49
JP Morgan Chase
New York
$844 -$411K -22,910 -100%
FDCDDQ
50
Federation des caisses Desjardins du Quebec
Quebec, Canada
$620 – – –
1
2
3

QTTB Hedge Fund Activity: Q2 2023 in Review

59 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q2 2023, worth a combined $15.9M — down 21% from $20M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of QTTB and 7 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 6 added.

The largest buyer was Assenagon Asset Management, adding an estimated $31.7K. The largest seller was JP Morgan Chase, cutting an estimated $411K.

  • 59 institutional investors held Q32 Bio (QTTB) as of Q2 2023, down from 62 in Q1 2023.
  • Funds reported $15.9M of Q32 Bio stock for Q2 2023, down 21% quarter-over-quarter.
  • 7 funds opened new Q32 Bio positions in Q2 2023 and 10 closed out, a net change of -3 holders.
  • The largest Q32 Bio buyer in Q2 2023 was Assenagon Asset Management, an estimated $31.7K added.
  • The largest Q32 Bio seller in Q2 2023 was JP Morgan Chase, an estimated $411K sold.

Based on aggregated 13F filings for Q2 2023.